Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.

TSX:MSCL - Post by User

Satellos Bioscience Inc > maybe next week they says something...like:

<< Previous

Bullboard Posts

Next >>

Comment by Alba1314on Jan 28, 2019 11:19am

41 Views

Post# 29288919

RE:RE:RE:RE:RE:RE:RE:maybe next week they says something...like:

guess it depends on how you look at it. Each trial/phase result will either be positive or negative. Seems a 50/50 chance to me. Better than Vegas, no? AND there's the free "Juansito" show. He aappears live, daily, for free...but today. He's unusually quiet today.

Hang in there my friend. You held on to a small position "just in case". They cant keep silent forever. Eventually they'll release something...making some of us either princes or paupers

<< Previous

Bullboard Posts

Next >>

How to decrease sector risk by owning hundreds of mineral assets